People · Operator
Named in public records as an officer, director or promoter · active 2017–2024 · Other Technology, Other, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| 23andMe, Inc. | — | Other Technology | Series D+ | $819.5M | $2.3B | 2020 |
| DiCE MOLECULES HOLDINGS, LLC | — | Other Technology | Series C | $158.8M | $1.3B | 2018 |
| Medrio, Inc. | — | Other | Series B | $27.0M | $415.4M | 2017 |
| Aarvik Therapeutics, Inc. | — | Pharmaceuticals | Series A | $9.5M | $5.1M | 2021 |
Richard Scheller at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Richard Scheller on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Ryan Drant | 1 | 24 |
| Patrick Chung | 1 | 10 |
| Esther Dyson | 1 | 9 |
| Michael Rubin | 1 | 8 |
| ROELOF BOTHA | 1 | 6 |
| Jake Simson | 1 | 6 |
| Sharon Tetlow | 1 | 4 |
| Anula Jayasuriya | 1 | 4 |
| Shaan Gandhi | 1 | 4 |
| John Bedbrook | 1 | 3 |
| Andrew Page | 1 | 3 |
| Scott Robertson | 1 | 3 |
| Kevin Judice | 1 | 3 |
| Bradley Sloan | 1 | 2 |
| Stephen Zachary | 1 | 2 |
| Pehr Harbury | 1 | 2 |
| Neal Mohan | 1 | 2 |
| Linda Avey | 1 | 2 |
| Jim Scopa | 1 | 2 |
| Michael Rabson | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.